Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations
Regina Murphy, McKesson Specialty Care Solutions
Advertisement
Articles by Regina Murphy, McKesson Specialty Care Solutions
Advertisement
Latest Updated Articles
- Dealing With REMS Challenges in Drug Commercialization
Published: August 19th 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
2
The Hidden Costs of Specialty Drug Access and Patient Loneliness
3
Frontier Scientific Solutions, ATSG Partner to Launch Air Network for Temperature-Controlled Pharmaceuticals
4
Mark Cuban Confirms Cost Plus Drugs Partnership
5
